Wharton’s Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study

Table 2

Number and percentage of nonresponders in subgroups categorized by number of past WJ-MSC administrations.

	Number of past WJ-MSC administrations
	Course 1					Course 2
	1	2	3	4	5	6	7	8	9
Number of patients	9	5	4	29	2	0	2	1	2
QoL nonresponders	2 (22.2%)	1 (20.0%)	2 (50%)	2 (6.9%)	0 (0%)	0	0	0	0
Self-service nonresponders	8 (88.9%)	4 (80.0%)	4 (100%)	16 (55.2%)	1 (50%)	0	0	0	0
Total nonresponders	2 (22.2%)	1 (20.0%)	2 (50%)	2 (6.9%)	0 (0%)	0	0	0	0

QoL: quality of life; WJ-MSC: Wharton’s jelly mesenchymal stem cells.